600513 联环药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.37510.30311.66110.66010.000
总资产报酬率 ROA (%)1.1454.8475.5775.3975.230
投入资产回报率 ROIC (%)1.4866.4167.4617.3236.795

边际利润分析
销售毛利率 (%)49.14148.13753.34854.63153.837
营业利润率 (%)8.8348.0399.5679.49310.332
息税前利润/营业总收入 (%)9.9309.22310.71810.80011.436
净利润/营业总收入 (%)7.0016.9618.5138.5008.669

收益指标分析
经营活动净收益/利润总额(%)100.12590.236100.86797.45297.813
价值变动净收益/利润总额(%)-2.166-0.241-1.514-0.941-0.551
营业外收支净额/利润总额(%)-0.2250.1491.0612.087-0.877

偿债能力分析
流动比率 (X)1.1001.0861.1001.1821.292
速动比率 (X)0.8520.8330.8760.9831.055
资产负债率 (%)45.08046.86747.92845.60442.315
带息债务/全部投入资本 (%)36.54437.12337.35133.651--
股东权益/带息债务 (%)172.067167.777166.714196.041255.885
股东权益/负债合计 (%)108.694101.18097.342107.845123.586
利息保障倍数 (X)8.8967.87110.2249.7729.577

营运能力分析
应收账款周转天数 (天)85.52680.90880.47783.8130.000
存货周转天数 (天)101.93994.95995.11695.8370.000